Lipohypertrophy
Abnormal fat accumulation at insulin injection sites that can interfere with diabetes management and complicate weight loss efforts.
Plain English
Patient-Friendly Explanation
Lipohypertrophy is the abnormal accumulation of fat in specific areas, often as a reaction to repeated insulin injections in diabetes patients. These lumpy fat deposits can interfere with insulin absorption and make weight management more difficult.
Medical
Clinical Definition
Lipohypertrophy is a localised hypertrophy of subcutaneous adipose tissue, commonly seen at insulin injection sites due to the lipogenic effects of insulin. It impairs insulin absorption, leading to glycaemic variability and higher insulin requirements, creating a cycle of increased dosage and further lipohypertrophy.
Key Insight
Why It Matters
For patients managing both diabetes and weight, lipohypertrophy complicates treatment. Accord Medical helps patients identify and manage injection-site issues as part of a holistic weight management plan that addresses both metabolic health and medication effectiveness.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: August 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.
